Results from small animal radiation research platform feature in key papers
Xstrahl presented its full range of superficial/orthovoltage treatment systems and radiation research platforms at ESTRO 2019 in Milan.
The new Xstrahl 150 device will be the company’s most comprehensive superficial system dedicated to skin cancer treatments, offering clinicians the ability to treat the full range of non-melanoma skin cancer cases with optimum dose control. It includes several features that enhance the capabilities of Xstrahl’s current 150kV superficial system, including built-in dosimetry control, filter and applicator recognition and suitability for use with oval applicators.
The energy range of the Xstrahl 150 means that superficial lesions can be successfully treated, from basal cell carcinoma and squamous cell carcinoma to keloid scars and dermatological conditions such as psoriasis.
Other products in Xstrahl’s range of superficial and orthovoltage treatment systems were also in the spotlight at the event, including the RADiant 80kV treatment system for dermatological applications and the Xstrahl 300kV system for treating non-melanoma skin cancer, benign and palliative conditions.
Xstrahl says its small animal radiation research platform (SARRP) is the most advanced commercially available 3D image-guided micro irradiator and serves as a dynamic research tool for preclinical radiobiology research. Results of research carried out on SARRP systems in Oxford, France and Germany featured in some of the key papers being presented at the meeting.
Published on page 4 of the June 2019 issue of RAD Magazine.
